What is the share price of Sunrest Lifescience Ltd (SUNREST) today?
The share price of SUNREST as on 7th July 2025 is ₹50.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Sunrest Lifescience Ltd (SUNREST) share?
The past returns of Sunrest Lifescience Ltd (SUNREST) share are- Past 1 week: -10.00%
- Past 1 month: 0.80%
- Past 3 months: -4.09%
- Past 6 months: -7.86%
- Past 1 year: -21.25%
- Past 3 years: N/A%
- Past 5 years: -36.84%
What are the peers or stocks similar to Sunrest Lifescience Ltd (SUNREST)?
The peers or stocks similar to Sunrest Lifescience Ltd (SUNREST) include:What is the market cap of Sunrest Lifescience Ltd (SUNREST) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sunrest Lifescience Ltd (SUNREST) is ₹21.63 Cr as of 7th July 2025.What is the 52 week high and low of Sunrest Lifescience Ltd (SUNREST) share?
The 52-week high of Sunrest Lifescience Ltd (SUNREST) is ₹75 and the 52-week low is ₹44.60.What is the PE and PB ratio of Sunrest Lifescience Ltd (SUNREST) stock?
The P/E (price-to-earnings) ratio of Sunrest Lifescience Ltd (SUNREST) is 10.76. The P/B (price-to-book) ratio is 1.53.Which sector does Sunrest Lifescience Ltd (SUNREST) belong to?
Sunrest Lifescience Ltd (SUNREST) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Sunrest Lifescience Ltd (SUNREST) shares?
You can directly buy Sunrest Lifescience Ltd (SUNREST) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Sunrest Lifescience Ltd
SUNREST Share Price
50.400.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
SUNREST Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
SUNREST Performance & Key Metrics
SUNREST Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.53 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.69 | 6.41 | 0.79% |
SUNREST Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
SUNREST Company Profile
Sunrest Lifescience is engaged in the marketing of over the counter (OTC) generic pharmaceutical products manufactured by third party manufacturers in the domestic market.
SUNPHARMA
PE Ratio
36.72
36.72
1Y Return
7.46%
7.46%
Buy Reco %
87.50
87.50
CIPLA
PE Ratio
22.80
22.80
1Y Return
0.08%
0.08%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.83
58.83
1Y Return
15.25%
15.25%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.89
18.89
1Y Return
1.76%
1.76%
Buy Reco %
55.17
55.17
MANKIND
PE Ratio
50.40
50.40
1Y Return
17.92%
17.92%
Buy Reco %
81.25
81.25
SUNREST Forecast
SUNREST Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
SUNREST
SUNREST
Income
Balance Sheet
Cash Flow
Annual Normal View
SUNREST Income Statement
SUNREST Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.95 | 16.95 | 26.91 | 24.67 | 29.48 | 33.42 | — | |||||||
Raw Materials | 7.37 | 12.40 | 18.24 | 16.52 | 21.09 | 30.39 | — | |||||||
| Power & Fuel Cost | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | |||||||||
| Employee Cost | 2.06 | 2.37 | 2.54 | 2.90 | 3.59 | |||||||||
| Selling & Administrative Expenses | 1.26 | 2.67 | 4.54 | 3.27 | 4.39 | |||||||||
| Operating & Other expenses | 0.11 | -0.78 | 0.46 | -0.97 | -0.50 | |||||||||
EBITDA | 0.15 | 0.28 | 1.13 | 2.94 | 0.90 | 3.03 | — | |||||||
| Depreciation/Amortization | 0.02 | 0.04 | 0.06 | 0.13 | 0.10 | 0.10 | — | |||||||
| PBIT | 0.13 | 0.24 | 1.07 | 2.81 | 0.80 | 2.93 | — | |||||||
| Interest & Other Items | 0.00 | 0.01 | 0.02 | 0.06 | 0.22 | 0.31 | — | |||||||
| PBT | 0.13 | 0.23 | 1.05 | 2.75 | 0.58 | 2.62 | — | |||||||
| Taxes & Other Items | 0.10 | 0.05 | 0.27 | 0.70 | 0.36 | 0.61 | — | |||||||
| Net Income | 0.03 | 0.18 | 0.78 | 2.05 | 0.22 | 2.01 | — | |||||||
| EPS | 0.10 | 0.60 | 2.60 | 6.83 | 0.60 | 4.67 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
SUNREST Company Updates
SUNREST Stock Peers
SUNREST Past Performance & Peer Comparison
SUNREST Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Sunrest Lifescience Ltd | 10.76 | 1.53 | — |
| Sun Pharmaceutical Industries Ltd | 36.72 | 5.54 | 0.96% |
| Cipla Ltd | 22.80 | 3.84 | 1.07% |
| Torrent Pharmaceuticals Ltd | 58.83 | 14.81 | 0.18% |
SUNREST Stock Price Comparison
Compare SUNREST with any stock or ETFCompare SUNREST with any stock or ETF
SUNREST
SUNREST Holdings
SUNREST Shareholdings
SUNREST Promoter Holdings Trend
SUNREST Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
SUNREST Institutional Holdings Trend
SUNREST Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
SUNREST Shareholding Pattern
SUNREST Shareholding Pattern
SUNREST Shareholding History
SUNREST Shareholding History
Foreign Institutions
smallcases containing SUNREST stock
smallcases containing SUNREST stock
Looks like this stock is not in any smallcase yet.
SUNREST Events
SUNREST Events
SUNREST Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUNREST has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
SUNREST Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
SUNREST has not given any dividends in last 5 years
SUNREST Dividends
SUNREST Dividends
Hmm, looks like data is unavailable here. Please come back after some timeSUNREST Stock News & Opinions
SUNREST Stock News & Opinions
Articles & Videos
Corporate
Sunrest Lifescience to table results
Sunrest Lifescience will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Sunrest Lifescience to hold board meeting
Sunrest Lifescience will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Sunrest Lifescience schedules AGM
Sunrest Lifescience announced that the 7th Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 25%, vs industry avg of 10.1%
Over the last 5 years, market share increased from 0% to 0.01%
Over the last 5 years, net income has grown at a yearly rate of 131.85%, vs industry avg of 20.04%